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Abstract 
Background: Verb fluency (VF) is the less commonly used fluency test, despite several studies 
have suggested its potential as a neuropsychological assessment tool. Objective: The aims of this 
study were to investigate the presence of VF deficits in patients with mild cognitive impairment 
(MCI) and mild AD dementia; to assess the usefulness of VF in the detection of cognitively 
healthy (CH) people who will convert to MCI, and from MCI to dementia; and to establish the 
VF cut-off scores of impairment that could be useful in the cognitive assessment of Spanish 
population. Methods: 568 CH, 885 MCI and 367 mild AD dementia individuals were 
administered the VF test and a complete neuropsychological battery. Longitudinal analyses were 
performed in 231 CH and 667 MCI subjects to search for the VF predictors 
of diagnosis conversion. Results: Lower performances on VF were significantly related to 
conversion from CH to MCI, and also from MCI to dementia. When the effect of 
time to conversion was analyzed, a significant effect of VF was found on the faster conversion 
from CH to MCI, but not from MCI to dementia. Moreover, VF cut-off scores and 
sensitivity/specificity values were calculated for 6 conditions (3 age ranges by 2 educational 
levels). Conclusions: The VF test may be useful in the detection of the different stages of 
cognitive decline due to AD. Since VF deficits seem to take place in early stages of the disease, 
it is a suitable neuropsychological tool for the detection not only of CH people who will convert 
to MCI, but also from MCI to dementia.  
 
 
 
Keywords: Verb fluency, verbal fluency, Mild cognitive impairment, cognitively healthy, 
Alzheimer’s disease. 
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INTRODUCTION 
 Verbal fluency refers to the ability to generate spoken or written words in a given time, 
usually one minute [1]. Verbal fluency tests, such as letter and category fluencies, are often 
included in neuropsychological test batteries as a measure of language and executive functions 
[2] due to their shortness and ease of administration, without the need for any other instrument 
than a stopwatch.  
In general terms, verbal fluency tasks require preserved language and executive functions 
to be properly performed [2–5]. These tasks may be particularly useful discriminating between 
normal and impaired cognitive abilities [6–8]. Therefore, verbal fluency tasks have been 
incorporated in screening tools designed to detect cognitive deficits such as the Addenbrooke’s 
Cognitive Assessment (ACE) [9,10], the Dementia Rating Scale (DRS) [11,12] or the Edinburgh 
Cognitive Assessment (ECAS) [13]. Verbal fluency tests have been used in a wide range of 
neurological diseases such as Alzheimer’s disease (AD) [14], neurodegeneration coursing with 
movement disorders [15,16], multiple sclerosis [17] and human immunodeficiency virus (HIV) 
[18]. 
 Interestingly, several studies have reported that each type of verbal fluency may be 
sensitive to different aspects of cognitive functioning and, consequently, to the functioning of 
different cerebral structures. Indeed, the results of case studies have demonstrated that verb and 
noun retrieval are subserved by different anatomical substrates [19–21]. In addition, studies of 
patients with different neurodegenerative disorders, such as AD [22,23], Parkinson’s disease 
[24–27], frontotemporal dementia [28,29], motor neuron disease [16,30] and HIV [18], have 
described qualitatively different performances in each type of these verbal fluency tasks. 
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Previous research has suggested that verbal fluency tests are useful, not only to 
differentiate between healthy individuals from those with cognitive impairment or dementia [31–
36], but also to discriminate between converters and non-converters to dementia from mild 
cognitive impairment (MCI) [37–39]. However, most of these studies used category and letter 
fluency to assess their subjects, not verb fluency. That is, the less common test of verbal fluency 
is the verb fluency task. Indeed, verb fluency has not been frequently used in neuropsychological 
assessment, whereas nowadays, due to several studies suggesting the potential of this tool [40], 
the use of verb fluency is increasing. 
The verb fluency refers to the generation of as many verbs (or actions or things that 
people do) as possible in a given time, allowing the production of verbs denoting concrete 
actions (i.e., to run) or internal states (i.e., to think) [21]. This type of verbal fluency task 
assesses language and executive functions and it is sensitive to dysfunctions in fronto-subcortical 
networks linking primary and secondary motor cortex, frontal lobes and basal ganglia [19–
21,23,40–44]. Since the generation of verbs has also been related to neocortical-hippocampal 
interaction, mainly the perirhinal cortex, which receives reciprocal inputs from associative 
regions (prefrontal, insular and anterior cingulate cortices) [45], verb fluency has been proposed 
as a sensitive test detecting early dysfunctions associated with AD.  
The verb fluency task seems to be more cognitively demanding than other verbal fluency 
tasks [40,44]. Accordingly, healthy adults perform worse on generating verbs than  nouns 
[23,46]. The reasons for this discrepancy could be partly grammatical. In fact, in many languages 
the verb morphology tends to be more complex than noun morphology, yet they could also 
reflect deeper conceptual differences, with action semantics underlying verb production being 
more complex than that of nouns [47].  
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 Following this line of reasoning, we hypothethized that verb fluency may be a useful tool 
to assess cognition. Thus, the main aims of the present study were: 1) to investigate the presence 
of deficits in verb fluency in patients with MCI and mild AD dementia and to assess the potential 
usefulness of the verb fluency for the detection of healthy aging people who will convert to MCI, 
or from MCI to dementia; and 2) to establish the verb fluency cut-offs scores of impairment that 
could be useful in the cognitive assessment of Spanish population. 
 
METHODS 
Subjects and Study design 
 This study was divided into two parts: (I) a cross-sectional study including all 
Cognitively Healthy (CH) individuals, subjects with MCI and patients with mild dementia due to 
AD who fulfilled the inclusion criteria for the present study; and (II) a longitudinal study 
searching for the verb fluency predictor value of conversion of diagnosis (from CH to MCI and 
from MCI to dementia), among those CH and MCI subjects who had at least one follow-up 
assessment. 
 The study was conducted in Fundació ACE, Institut Català de Neurociències Aplicades 
(Barcelona, Spain), a non-profit Alzheimer’s center that provides diagnostic, treatment and 
patient management services to the Catalan Public Health Service (Xarxa Hospitalària 
d’Utilització Pública (XHUP)  [48]. Subjects are usually referred to the Memory Clinic of 
Fundació ACE by primary care physicians or medical specialists because the subjects, their 
families, or their physician felt that they could have a memory loss or cognitive decline in other 
domains. In the diagnostic procedure, we used cut-off scores for determining the presence or 
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absence of cognitive impairment. These cut-off scores were obtained from a representative 
sample of our target population older than 44 years. See [7] for more details. 
 
Inclusion and exclusion criteria 
 The general inclusion criteria for all subjects regardless to the group they belonged were: 
1) subjects older than 44 years old, 2) educational level of at least elementary school (that is, at 
least 6 years of formal education)  to be able to complete the neuropsychological battery; 3) had 
completed the verb fluency test and had been administered the Neuropsychological Battery from 
Fundació ACE (NBACE) [7,49]; 4) had completed the diagnostic procedure with a baseline final 
diagnosis of CH, MCI or mild dementia due to AD. 
For the CH group the following inclusion criteria were considered: 1) being classified as 
“without objective cognitive impairment”; 2) no neurologic symptoms reported either by the 
participant or an informant; 3) a Clinical Dementia Rating (CDR) [50] of zero; 4) average or 
above average scores on the NBACE, score ≥ 12 on the Memory test of the 7 Minute Screen test 
[51,52] and score ≥ 24 on the Mini-Mental State Examination (MMSE) [53,54]; 5) no history of 
functional impairment due to declining cognition; 6) a score < 4 on the Blessed Dementia Rating 
Scale (BDRS) [55,56]. 
 The inclusion criteria for the MCI group were: 1) subjective memory complaints; 2) 
normal general cognition as measured by the MMSE; 3) preserved performance in activities of 
daily living; 4) absence of dementia; 5) an objective measurable impairment in memory or 
another cognitive function with or without impairment in other cognitive domain (MCI amnestic 
or non-amnestic single or multiple domain [57]).  
 6 
 
 The inclusion criteria for the AD dementia group were: 1) diagnosis of dementia 
syndrome due to AD [58]; 2) mild severity of dementia determined by a total score of 1 in the 
CDR; 3) a MMSE score > 19.  
 The exclusion criteria were: 1) age younger than 45 years old because the authors had no 
normative data for this age group; 2) educational level below Elementary School to correctly 
understand the instruction of the verb fluency test; 3) MMSE score below 20; 4) Global 
Deterioration Scale (GDS) [59] score > 4 or an MCI or dementia of the non-AD type. 
 In the diagnosis procedure, all of the participants received an extensive clinical 
evaluation including a complete neuropsychological assessment (for details see below), a 
neurological history and examination and a semi-structured psychosocial interview conducted by 
a social worker. Moreover, patients’ functionality was assessed by the Blessed Dementia Scale 
[55,56].  
Prior to the evaluation a written informed consent was obtained from all participants and 
in those cases of patients with dementia, also by their caregivers. The study was conducted in 
accordance with the Declaration of Helsinki and with Spanish biomedical laws (Law 14/2007, 
July 3rd, about biomedical research; Royal Decree 1716/2011, November 18th). The study was 
approved by the Fundació ACE Research Ethics Committee.  
Neuropsychological assessment 
 The NBACE was administered in the diagnostic procedure. It assesses cognitive 
functions relevant to the diagnosis of neurodegenerative disorders. Its administration takes 
approximately 45 minutes and includes the following tests: Temporal, Spatial and Personal 
Orientation; Digit Span (forward and backwards), Block Design (abbreviated in 4 items) and 
Similarities (abbreviated to the first 10 items) subtests extracted and adapted from the Wechsler 
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Adult Intelligence Scale-Third Edition (WAIS-III); The Word List Learning test from the 
Wechsler Memory Scale-Third Edition (WMS-III) (without using the interference list); 
Repetition (2 words and 2 sentences); Verbal comprehension (to correctly execute 2 simple, 2 
semi-complex and 2 complex commands); an abbreviated 15-item Boston Naming Test (15-
BNT); the Poppelreuter test; Luria’s Clock test; the Automatic Inhibition subtest of the 
Syndrome Kurtz Test (SKT); Letter Fluency (it required to name as many words as possible 
beginning with the letter “p” in one minute); Category Fluency (to name as many words 
belonging to the semantic category “animals” as they could in one minute); 4 item Imitation 
praxis; 4 item Ideomotor commands; and the 15-Objects Test (15-OT). Normative data and cut-
off scores of NBACE subtests have been reported elsewhere [7,49]. 
 The verb fluency task was added for the purpose of the present study and its scores were 
not taken into account when diagnosing the participant. Note that when the authors devised the 
early version of the NBACE (2006), the assessment of verb fluency was not popular among 
general test batteries of cognitive decline. Participants were asked to name as many verbs in 
infinitive or actions as possible in one minute. They had to say the verbs in infinitive, but if they 
named some inflection or repetition of a verb, only the first one was considered as correct. When 
the participant needed an example to understand the task, they were told the following sentence: 
“Something that we can do such as to sing” [60]. All types of verbs were allowed even abstract 
verbs. The total score consisted of the total correct answers. Errors were not registered. 
Statistical analysis 
 Statistical analysis was carried out using SPSS 20.0 (SPSS Inc., Chicago, IL). Normal 
distribution of the data was verified before conducting the statistical analyses. In the Cross-
sectional study, One factor Analysis of Variance (ANOVA), with contrasts, was carried out to 
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compare demographic and cognitive scores (verb fluency, NBACE and MMSE) between CH, 
MCI and AD dementia groups; and 2 for sex comparisons.  
 In the whole sample, Pearson’s correlation analyses were performed between verb 
fluency scores, age and years of education. Data of subjects with cognitive impairment (MCI and 
mild dementia) and CH were used to calculate cut-off scores and sensitivity/specificity values for 
six conditions after combining 3 age ranges (44 to 64; 65 to 74; and older than 74 years) by 2 
educational levels (elementary school (6-8 years) and more than elementary school (> 8 years). 
Receiver operating characteristic (ROC) analysis was used to establish the optimal cut-off values 
between cognitive impairment and CH groups, by calculating the sensitivity and specificity of 
verb fluency test cut-off values for the 6 (age by education) conditions. 
 In the longitudinal study, t-tests were used to compare verb fluency performances 
between converters and non-converters from CH to MCI, and from MCI to dementia. Logistic 
Regression analyses were performed to describe the predictive value of verb fluency test in the 
conversion from CH to MCI, and from MCI to dementia. Moreover, Cox Proportional Hazard 
models were carried out to measure the association between the verb fluency performance and 
time to convert from CH to MCI and from MCI to dementia diagnosis. 
 
RESULTS 
Cross-sectional study 
 A total of 1.820 subjects had been administered the verb fluency test and assessed by the 
neuropsychological battery NBACE. They completed the diagnostic procedure with a final 
diagnosis of CH (n = 568, 31.2%), MCI (n = 885, 48.6%, 535 amnestic and 350 non amnestic) or 
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mild dementia due to AD (n = 367, 20.2%). Demographic data are detailed in Table 1. Mean and 
standard deviation (SD) of the verb fluency and NBACE subtests scores are detailed in Table 2.  
----------------------------------------------------------- 
Insert Table 1 and Table 2 about here 
----------------------------------------------------------- 
As shown in Figure 1, verb fluency test provided a statistically significant worsening on 
performance from HC to MCI and mild AD dementia groups; and in Figure 2 is shown it 
including amnestic and non-amnestic MCI groups. 
----------------------------------------------------------- 
Insert Figure 1 and Figure 2 about here 
----------------------------------------------------------- 
 
 Data from 1.252 patients with cognitive impairment (MCI and mild AD dementia) and 
568 CH subjects were taken to calculate verb fluency cut-off scores in relation to age and 
education (see Table 3). 
 In the whole sample, lower verb fluency scores were significantly correlated with older 
age (r = -0.44, p < 0.001) and lower education (r = 0.50, p < 0.001), but not with sex (t = -1.04, p 
= 0.300). Interaction between age and education was statistically significant (F = 5.78, p = 
0.003). For this reason, cut-offs were reported after combining 3 age ranges (45-64, 65-74 and > 
74) by 2 educational levels (elementary school and > elementary school) (see Table 3 for 
details).  
----------------------------------------------------------- 
Insert Table 3 about here 
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----------------------------------------------------------- 
 
Longitudinal study 
 From the 568 CH subjects and 885 patients with MCI, 231 and 667 were followed-up, 
respectively. Mean time follow-up was 19.3 months (SD = 12.2) in CH subjects and 16.6 months 
(SD = 9.5) in the MCI group. With regard to CH group, the 18.2% of subjects (n = 42) had 
converted to MCI at the time of follow-up. The mean annual conversion rate for this group was 
12.1%. The conversion rate of patients with MCI (n= 144) to dementia (106 patients or 71.1% 
AD dementia, 25 patients or 16.8% vascular dementia, 9 patients or 6% fronto-temporal 
dementia, 9 patients or 6% with parkinsonism) at the time of the follow-up was 21.6%. The 
annual conversion rate for this group was 15.6%. 
 With regard to CH group, converters to MCI had worse baseline performances on verb 
fluency test than those who maintained a stable performance (converters to MCI: mean= 13.9, 
SD= 4.9, non-converters: mean= 18.7, SD= 6.3; t= 4.63, p < 0.001). Those MCI patients who 
converted to dementia performed significantly worse on verb fluency (converters to dementia: 
mean= 9.4, SD= 5.6, non-converters: mean= 10.9, SD= 5.7; t= 2.933, p= 0.003) than those who 
did not convert. A Logistic Regression analysis introducing the verb fluency test, adjusting for 
age, showed that this test was significantly related to conversion from CH to MCI (Wald = 
15.186, OR = 0.87, p < 0.001); and also significantly related to conversion from MCI to 
dementia (Wald = 4.503, OR = 0.96, p < 0.034).  
 A Cox Proportional Hazard model was carried out to measure the association between the 
verb fluency variable and time to convert from CH to MCI, controlling for age, showed that verb 
fluency had a statistically significant effect (Wald = 7.922, p = 0.005, HR= 0.90; CI 95 0.842-
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0.970). Another Cox Proportional Hazard model, controlling for age, was performed to measure 
the association between the verb fluency variable and time to develop dementia from MCI. It 
showed that verb fluency had not any statistically significant effect.  
 
DISCUSSION 
 The results of the present study reveal that verb fluency test can be a useful tool for the 
differential diagnosis of cognitive failure in the elderly. Verb fluency test provide a useful 
gradation of impairment from normal aging to MCI and mild AD as reported in previous studies 
with verbal fluency tests [6,7,26,32,33,61]. 
  Consistent with a previous study in healthy Spanish subjects [62], higher levels of 
schooling were found related to better verb fluency performance. Moreover, in contrast to CH 
subjects, patients with cognitive impairment (MCI and mild AD dementia groups) obtained 
lower performances on verb fluency. Thus, verb fluency might be a suitable tool to detect subtle 
performance deficits in patients with MCI and mild dementia who otherwise perform normally 
on other verbal fluency tests. This is consistent with the results of a cross-sectional study [63] in 
which verb fluency, compared to letter and category fluencies, was found disproportionately 
impaired in MCI and was suggested as a possible linguistic marker for the progression from the 
subjective memory impairment to MCI diagnosis. From the standpoint of cognitive 
neuroscience, in contrast to the semantic representation of nouns in the brain that seems to be 
organized in a systematic, taxonomical way, which may imply an overlap among related 
semantic neuronal sets [64,65], in the case of verbs such taxonomies might play a less 
pronounced role, with less overlapping word meanings, making the verb fluency task more 
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difficult [44,63]. From a linguistic point of view, verbs are often more complex than nouns, 
displaying features such as argument structure and, in many languages, more complex 
morphology [47]. 
 Since most of the decrease in verb fluency seems to take place already in the early stages 
of AD, decreased performance on this task may herald the conversion from CH to MCI, but is 
less sensitive to detect the further progression of the disease. In support of this argument, when 
the time of conversion was taken into account in the Cox Regression analyses, the verb fluency 
only showed a significant effect on the faster conversion from CH to MCI, but not from MCI to 
dementia, findings that concur with results of previous studies using category [37,38,66] and 
letter verbal fluencies [38,66]. 
 Similar to another study in Spanish speakers [62], having fewer years of schooling and 
older age were significantly related to worse performances on verb fluency, but sex did not affect 
performance. Since we found that verb fluency is useful to detect cognitive impairment and it is 
related to age and education, we decided to detail cut-off scores segregated by age and education. 
That is, those subjects with scores lower than their corresponding cut-off (taking their age and 
educational level) would be probably cognitively impaired (MCI or AD dementia), and those 
with scores higher than their cut-off could be taken as cognitively preserved. Thus, data reported 
here are complementary with the results of our own previous studies [7,49] in setting the relevant 
cut-off scores for impaired function and decision making algorithms for use in identifying adult 
individuals with cognitive impairment.  
A limitation of the present study was that cerebrospinal fluid biomarkers were not 
available, but we considered that it was not a critical matter for the purpose of the present study. 
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Lumbar puncture is not a mandatory technique in Spain for MCI and AD diagnosis in the clinical 
practice in our country. 
 Further research will be needed to analyze the ability of verb fluency to discriminate 
between converters and non-converters to AD among cognitively healthy individuals with 
subjective cognitive decline.  
In conclusion, verb fluency test may be a useful tool in the detection of the different stages 
of cognitive decline associated with AD. Since the verb fluency seems to take place in the early 
stages of the disease, it is a suitable neuropsychological tool for the detection of healthy aging 
people at risk of converting to MCI. Nevertheless, the findings of the present study support the 
usefulness of verb fluency test in the context of a complete neuropsychological assessment, but 
not when it is used in isolation. 
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Table 1. Demographic characteristics of participants. 
 CH MCI AD Statistics 
N 568 885 367 
 
Sex n (%) Male 177 (31.2) 369 (41.7) 132 (36.0) 16.71
*** 
Education in years 
(mean/SD) 
11.9 (3.6) 9.3 (3.4) 8.9 (3.4) 122.82
*** 
Age in years  
(mean/SD) 
63.3 (7.8) 71.7 (8.9) 79.0 (7.6) 414.82
*** 
Notes.  CH: Cognitively Healthy; MCI: Mild Cognitive Impairment; AD: mild AD dementia. 
SD: Standard deviation; 1: χ2; 2: F. 
*** p< 0.001 
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Table 2. Neuropsychological performance of the study subjects. 
 CH MCI AD dementia F (2, 1817) 
Verb fluency 18.97 (6.35) 10.72 (5.67) 7.20 (4.45) 573.07*** 
Total Orientation 14.97 (0.19) 14.59 (0.90) 12.13 (2.07) 802.37*** 
Memory     
Verbal Learning WMS-III 30.16 (4.77) 20.98 (5.80) 13.13 (4.62) 1217.88*** 
Delayed Recall WMS-III 7.49 (1.84) 3.40 (2.50) 0.41 (0.87) 1405.09*** 
Recognition WMS-III 23.02 (1.16) 20.22 (2.91) 15.75 (3.16) 899.92*** 
Digit Span Forward 5.68 (1.06) 5.18 (1.10) 4.94 (1.06) 59.19*** 
Digit Span Backwards 4.25 (0.86) 3.35 (0.97) 2.86 (1.05) 317.96*** 
Praxis     
Ideomotor 4.0 (0.6) 3.98 (0.17) 3.93 (0.30) 14.25*** 
Construction 3.93 (0.29) 3.20 (1.00) 2.52 (1.19) 264.41*** 
Imitation 3.96 (0.22) 3.46 (0.84) 2.68 (1.07) 298.22*** 
Language     
Visual Naming (15-BNT) 14.85 (0.41) 13.58 (1.89) 11.46 (2.90) 370.04*** 
Visual gnosis     
Poppelreuter test 9.97 (0.17) 9.42 (1.05) 8.33 (1.71) 265.02*** 
15-OT correct answers 14.01 (0.99) 11.52 (2.46) 8.77 (2.88) 617.02*** 
Luria’s Clock test* 3.82 (0.43) 3.16 (1.02) 2.04 (1.33) 385.58*** 
Executive functions      
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Syndrom Kurtz Test (sec)  21.60 (5.11) 35.05 (15.02) 44.32(16.53) 348.15*** 
Syndrom Kurtz Test (errors) 0.39 (0.96) 1.94 (2.52) 3.94 (3.60) 226.00*** 
Letter fluency 16.78 (4.22) 11.39 (4.52) 8.94 (4.46) 415.13*** 
Category fluency 20.92 (4.49) 13.51 (4.64) 8.77 (3.75) 922.97*** 
Abstract Reasoning 13.32 (1.61) 9.81 (3.00) 6.97 (3.20) 639.24*** 
Global cognition     
Clock Test 6.94 (0.42) 6.12 (1.53) 4.14 (2.10) 399.15*** 
MMSE score 29.41 (0.92) 27.42 (1.91) 23.28 (2.54) 1263.57*** 
Notes. CH: Cognitively Healthy; MCI: Mild Cognitive Impairment; AD: Alzheimer’s disease. 
The results are shown as Mean (Standard Deviation). 
***p< 0.001; All scores significantly differed between CH, MCI and mild AD dementia groups.  
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Table 3. Verb fluency cut-off scores for age and education. 
 
Age 
45-64 65-74 ≥ 75 
Elementary School 
 
< 13 < 12 < 11 
SE= 78 SE= 71 SE= 78 
SP= 73 SP= 79 SP= 77 
> Elementary School < 18 < 16 < 17 
SE= 69 SE= 70 SE= 77 
SP= 72 SP= 67 SP= 85 
Notes. SE: Sensitivity; SP: Specificity. 
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Figure 1. Verb fluency performances of HC, MCI and mild AD dementia groups. 
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Figure 2. Verb fluency performances of HC, non amnestic MCI, amnestic MCI and mild AD 
dementia groups. 
 
 
 
